{"product_id":"lynparza","title":"Lynparza","description":"\n\u003cdiv\u003e\n    \u003ch4\u003eProduct Description for Lynparza (Olaparib)\u003c\/h4\u003e\n    \u003cp\u003eLynparza (Olaparib) is a groundbreaking medication designed for the treatment of certain types of cancer, particularly ovarian and breast cancers associated with BRCA mutations. As a targeted therapy, it works by inhibiting the enzyme PARP (poly ADP-ribose polymerase), which plays a crucial role in repairing damaged DNA in cancer cells.\u003c\/p\u003e\n    \n    \u003ch4\u003eIndications\u003c\/h4\u003e\n    \u003cp\u003eLynparza is primarily indicated for patients with:\u003c\/p\u003e\n    \u003cul\u003e\n        \u003cli\u003eOvarian cancer who have received three or more prior lines of chemotherapy.\u003c\/li\u003e\n        \u003cli\u003eBreast cancer with a BRCA mutation that has progressed after prior therapies.\u003c\/li\u003e\n        \u003cli\u003ePancreatic cancer with a BRCA mutation.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003ch4\u003eMechanism of Action\u003c\/h4\u003e\n    \u003cp\u003eThe drug exploits the concept of synthetic lethality, specifically targeting cancer cells that are already deficient in DNA repair mechanisms. By inhibiting PARP, Lynparza prevents cancer cells from repairing their DNA, leading to cell death.\u003c\/p\u003e\n\n    \u003ch4\u003eAdministration\u003c\/h4\u003e\n    \u003cp\u003eLynparza is administered orally, typically in the form of tablets. Patients are advised to follow their healthcare provider's instructions regarding dosage and schedule.\u003c\/p\u003e\n\n    \u003ch4\u003ePotential Side Effects\u003c\/h4\u003e\n    \u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n    \u003cul\u003e\n        \u003cli\u003eNausea\u003c\/li\u003e\n        \u003cli\u003eFatigue\u003c\/li\u003e\n        \u003cli\u003eAnemia\u003c\/li\u003e\n        \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003c\/ul\u003e\n    \u003cp\u003eIt is essential for patients to report any severe or unusual symptoms to their healthcare provider promptly.\u003c\/p\u003e\n\n    \u003ch4\u003eClinical Studies\u003c\/h4\u003e\n    \u003cp\u003eClinical trials have demonstrated that Lynparza can significantly prolong progression-free survival in patients with BRCA-mutated cancers compared to standard therapies, marking it as a pivotal advancement in oncology.\u003c\/p\u003e\n\n    \u003ch4\u003eConclusion\u003c\/h4\u003e\n    \u003cp\u003eLynparza (Olaparib) represents a significant advancement in the treatment of specific cancers, offering hope to patients with BRCA mutations. Always consult with a healthcare professional for personalized medical advice and to discuss the potential benefits and risks associated with this therapy.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"Magento","offers":[{"title":"100mg","offer_id":49881709183222,"sku":"Lynparza","price":666.5,"currency_code":"USD","in_stock":true},{"title":"150mg","offer_id":49881709215990,"sku":"Lynparza-1","price":897.75,"currency_code":"USD","in_stock":true}],"url":"https:\/\/chemistway.com\/products\/lynparza","provider":"Chemistway","version":"1.0","type":"link"}